Literature DB >> 9605673

Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification.

P Kienbaum1, N Thürauf, M C Michel, N Scherbaum, M Gastpar, J Peters.   

Abstract

BACKGROUND: Acute displacement of opioids from their receptors by administration of large doses of opioid antagonists during general anesthesia is a new approach for detoxification of patients addicted to opioids. The authors tested the hypothesis that mu-opioid receptor blockade by naloxone induces cardiovascular stimulation mediated by the sympathoadrenal system.
METHODS: Heart rate, cardiac index, and intravascular pressures were measured in 10 patients addicted to opioids (drug history; mean +/- SD, 71 +/- 51 months) during a program of methadone substitution (96 +/- 57 mg/day). Cardiovascular variables and concentrations of catecholamine in plasma were measured in the awake state, during methohexital-induced anesthesia (dose, 74 +/- 44 microg x kg(-1) x min(-1)) before administration of naloxone, and repeatedly during the first 3 h of mu-opioid receptor blockade. Naloxone was administered initially in an intravenous dose of 0.4 mg, followed by incremental bolus doses (0.8, 1.6, 3.2, and 6.4 mg) at 15-min intervals until a total dose of 12.4 mg had been administered within 60 min; administration was then continued by infusion (0.8 mg/h).
RESULTS: Concentration of epinephrine in plasma increased 30-fold (15 +/- 9 to 458 +/- 304 pg/ml), whereas concentration of norepinephrine in plasma only increased to a minor extent (76 +/- 44 to 226 +/- 58 pg/ml, P < 0.05). Cardiac index increased by 74% (2.7 +/- 0.41 to 4.7 +/- 1.7 min(-1) x m(-2)), because of increases in heart rate (89 +/- 16 to 108 +/- 17 beats/min) and stroke volume (+44%), reaching maximum 45 min after the initial injection of naloxone. In parallel, systemic vascular resistance index decreased (-40%). Systolic arterial pressure significantly increased (113 +/- 16 to 138 +/- 16 mmHg), whereas diastolic arterial pressure did not change.
CONCLUSIONS: Despite barbiturate-induced anesthesia, acute mu-opioid receptor blockade in patients addicted to opioids induces profound epinephrine release and cardiovascular stimulation. These data suggest that long-term opioid receptor stimulation changes sympathoadrenal and cardiovascular function, which is acutely unmasked by mu-opioid receptor blockade. Because of the attendant cardiovascular stimulation, acute detoxification using naloxone should be performed by trained anesthesiologists or intensivists.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605673     DOI: 10.1097/00000542-199805000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

Review 1.  Current concepts in pharmacotherapy of substance abuse.

Authors:  P C Gottschalk; L K Jacobsen; T R Kosten
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  [Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].

Authors:  T Sellmann; M Winterhalter; U Herold; P Kienbaum
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

Review 3.  Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.

Authors:  Stacey C Sigmon; Adam Bisaga; Edward V Nunes; Patrick G O'Connor; Thomas Kosten; George Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-12       Impact factor: 3.829

Review 4.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

5.  [Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].

Authors:  J Jage; F Heid
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

Review 6.  Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.

Authors:  Linda Gowing; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

7.  The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty.

Authors:  Nicholas J Connors; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2016-06-07

8.  In Reply: "The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty".

Authors:  Nicholas J Connors; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2016-10-24

9.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

10.  The Devil Is in the Details but the Details Are Not in NHAMCS.

Authors:  Nicholas J Connors; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.